期刊文献+

18α-、18β-甘草次酸对他林洛尔在Caco-2细胞上外向转运的影响 被引量:6

Effect of 18α-glycyrrhetinic acid and 18β-glycyrrhetinic acid on outward transport of talinolol in Caco-2 cell monolayers
原文传递
导出
摘要 目的:研究甘草次酸18位差向异构体即18α-甘草次酸(α-GA)、18β-甘草次酸(β-GA)对P-糖蛋白(P-gp)底物他林洛尔在Caco-2细胞上外向转运的调控作用。方法:建立Caco-2单层细胞模型,以P-gp底物他林洛尔为探针药物,评价α-GA、β-GA和P-gp抑制剂维拉帕米对他林洛尔在Caco-2细胞上外向转运的影响。HPLC法测定细胞转运液中他林洛尔的浓度,采用Luna C18色谱柱(4.6 mm×250 mm,5μm),流动相乙腈-甲醇-10 mmol·L-1醋酸铵(25∶10∶65,v/v/v),流速1.0mL·min-1,检测波长248 nm。结果:浓度为10μmol·L-1的α-GA、β-GA使他林洛尔TransportB-A增加,他林洛尔BL-AP表观渗透系数(Papp B-A)增大,对他林洛尔外向转运表现出诱导作用;α-GA诱导P-gp外排他林洛尔的能力强于β-GA。结论:α-GA、β-GA能诱导P-gp的外向转运,加速P-gp底物的外排,可能是甘草酸制剂增强肝脏解毒的机制之一。 OBJECTIVE To study the effects of C-18 epimers of glycyrrhetinic acid, 18u-glycyrrhetinic acid (a-GA) and 18/3 glycyrrhetinic acid (β GA), on outward transport of P gp substrate talinolol in Caco-2 cell monolayers. METHODS Appropri ate Caco-2 monolayers were established, talinolol was used as a probe drugs. The efflux of talinolol in Caco 2 monolayers after treated for 72 h by toGA ,β-GA and verapamil was investigated. HPLC was applied to detect the concentration of talinolol in transfer fluids. The analyte was separated on a Luna C18 column (4. 6 mm × 250 mm, 5 bcm) and an isocratic mobile phase of acetonitrile-methanol-water containing ammonium acetate (10 mmol.L-1 ) (25: 10:65, v/v/v) at a flow rate of 1.0 mL.min-1. The detection wavelength was 248 nm. RESULTS 1(1 umol.L-1 a-GA and β-GA increased the Transport DA of talino101 in the incubation for 72 h test. Papp B-A of talinolol was increased after treatment, a-GA and β-GA induced the efflux of talinolol in this test and the inducibility of α-GA was better than that of β-GA. CONCLUSION The results of the transport experiments of P- gp substrates on Caco-2 monolayers indicated that a-GA and β-GA can induce the efflux function of P-gp and accelerate the excretion of P-gp substrates. It may be one of the mechanisms of that glycyrrhizin preparation enhance liver detoxification.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第6期405-409,共5页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金项目(编号:30873114) 湖南省自然科学基金重点项目(编号:11JJ2052) 湖南省中医药科研计划项目(编号:2008086)
关键词 甘草次酸 差向异构体 P-糖蛋白 他林洛尔 外向转运 glycyrrhetinic acid epimeride P-glyeoprotein talinolol membrane transport
  • 相关文献

参考文献16

  • 1吴锡铭,吕坚,茹仁萍.甘草酸18H差向异构体的比较研究[J].中国药学杂志,1993,28(4):215-218. 被引量:22
  • 2吴锡铭,吕坚.甘草酸差向异构体对大鼠肝损害的治疗作用[J].中国药理学报,1992,13(4):370-374. 被引量:24
  • 3Zou Q, Wei P, Li J, et al. Simultaneous determination of 18alpha and 18beta glycyrrhetic acid in human plasma by LC - ESLMS and its application to pharmacokinetics[J]. Biomed Chromatogr, 2009, 23(1 ) :54 62.
  • 4Rossi T, Fano RA, Castelli M, et al. Correlation between high intake of glycyrrhizin and myolysis of the papillary muscles:.an experimental in vivo study[J]. Pharmacol Toxieol, 1999, 85(5):221 229.
  • 5Lin JH. Drug drug interaction mediated by inhibition and induction of P-glycoprotein[J]. Adv Drug Deliv Rev, 2003, 55 (1):53-81.
  • 6Schrickx J, Fink Gremmels J. P glycoprotein-mediated trans port of oxytetracycline in the Caco-2 cell model [J]. J Vet Pharmacol Ther, 2007, 30(1 ) :25-31.
  • 7Campeanu A. The cardiac insufficiency talinolol study (CITAS) study design[J]. Eur J Heart Fail, 2001, 3 (3) : 377- 380.
  • 8Weitschies W, Bernsdorf A, Giessmann T, et al. The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen[J]. Pharm Res, 2005, 22(5) :728 -735.
  • 9Oertel R, Richter K, Trausch B, etal. A quick, simple HPI.C method for determination of talinolol in serum[J]. Pharmazie, 1994, 49(4):291 -292.
  • 10Trausch B, Oertel R, Richter K, et al. Disposition and bio availability of the beta 1-adrenoceptor antagonist talinolol in man[J]. Biopharm Drug Dispos, 1995, 16(5):403- 414.

二级参考文献15

  • 1王宇光,杨明会,马增春,梁乾德,谭洪玲,肖成荣,高月.18β-甘草酸和18α-甘草酸对大鼠原代肝细胞CYP3A酶表达的影响[J].中国中药杂志,2009,34(3):307-311. 被引量:37
  • 2吴锡铭,吕坚,茹仁萍.甘草酸18H差向异构体的比较研究[J].中国药学杂志,1993,28(4):215-218. 被引量:22
  • 3王建民,刘荫秋,赖西南.正常脐静脉离体后不同时间内皮某些物质含量的变化[J].第三军医大学学报,1995,17(1):86-86. 被引量:16
  • 4吴锡铭,药学学报,1988年,23卷,161页
  • 5Zhao M Q,药学学报,1983年,18卷,325页
  • 6YEE S.In vitro permeability across Caco-2 cells(colonic)can predict in vivo(small intestinal)absorption[J].Pharm Res,1997,14(6):763-766.
  • 7ALLEN R H,ROBERT A C,PHILLIPS B.Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa[J].Pharm Res,1990,7(9):902-910.
  • 8GAN L L,DHIREN R T.Applications of the Caco-2 model in the design and development of orally active drugs:elucidation of biochemical and physical barriers posed by the intestinal epithelium[J].Adv Drug Deliv Rev,1997,23(1):77-98.
  • 9PATRICK A,RAF M.HPLC with programmed wavelength fluorescence detection for the simultaneous determination of marker compounds of integrity and P-gp functionality in the Caco-2 intestinal absorption model[J].J Pharm Biomed Anal,2004,34(5):971-978.
  • 10JULIE J,MICHEL D,RICHARD B L.Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols[J].Biochim Biophys Acta,2002,1542(1-3):149.

共引文献136

同被引文献56

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部